RVL Pharmaceuticals plc Shareholders' Equity
RVL Pharmaceuticals plc had Shareholders' Equity of $16.33 million as of 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2023-08-14
- 2023-06-30: Stockholders' Equity Attributable to Parent $16.33M.
- 2023-03-31: Stockholders' Equity Attributable to Parent $40.00M.
- 2022-12-31: Stockholders' Equity Attributable to Parent $51.09M.
- 2022-09-30: Stockholders' Equity Attributable to Parent $68.55M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2023-06-30 | $16.33M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $40.00M 10-Q · filed 2023-08-14 | |
| 2022-12-31 | $51.09M 10-Q · filed 2023-08-14 | |
| 2022-09-30 | $68.55M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $58.51M 10-Q · filed 2023-08-14 | |
| 2022-03-31 | $69.48M 10-Q · filed 2023-08-14 | |
| 2021-12-31 | $76.73M 10-Q · filed 2023-08-14 | |
| 2021-09-30 | $54.75M 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $68.45M 10-Q · filed 2022-11-10 | |
| 2021-03-31 | $85.20M 10-Q · filed 2022-11-10 | |
| 2020-12-31 | $93.86M 10-K · filed 2023-03-20 | |
| 2020-09-30 | $150.69M 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $130.91M 10-Q · filed 2021-11-15 | |
| 2020-03-31 | $143.74M 10-Q · filed 2021-11-15 | |
| 2019-12-31 | $114.71M 10-K · filed 2022-03-30 | |
| 2019-09-30 | $141.70M 10-Q · filed 2020-11-10 | $141.70M 10-Q · filed 2019-11-14 |
| 2019-06-30 | $254.79M 10-Q · filed 2020-11-10 | $257.91M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $378.33M 10-Q · filed 2020-11-10 | $381.24M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $383.85M 8-K · filed 2021-09-08 | $386.27M 10-K · filed 2019-03-28 |